Meta facebook tracking pixel

Past Workshops

  1. Update from the 2024 American Society of Hematology (ASH) Annual Meeting
  2. Update on Primary Central Nervous System Lymphoma (PCNSL)
  3. Update on CAR T-Cell Therapies
  4. Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to CurePart II of Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to Cure
  5. Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to CurePart I of Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to Cure
  6. Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches for Relapsed Refractory DLBCL
  7. Taking Your Blood Cancer Adherence Treatment on Schedule
  8. Update on Follicular Lymphoma
  9. CAR T-Cell Therapy: What’s New
  10. Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
  11. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
  12. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
  13. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
  14. Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches
  15. What’s New in Precision Medicine
  16. Update on CAR T-Cell Therapies
  17. Follicular Lymphoma: Treatment Progress
  18. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
  19. Non-Hodgkin Lymphoma: Current Treatment Progress
  20. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
  21. Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
  22. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
  23. What’s New In Precision Medicine
  24. Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting - "Advancing Equitable Cancer Care Through Innovation"Part II of Highlights from the 2022 ASCO Annual Meeting
  25. Update On Marginal Zone Lymphoma (MZL)
  26. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
  27. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
  28. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
  29. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
  30. Coping with the Stresses of Caregiving When Your Loved One Has Mantle Cell Lymphoma (MCL)Part II of Living with Mantle Cell Lymphoma (MCL)
  31. Mantle Cell Lymphoma: Treatment UpdatePart I of Living with Mantle Cell Lymphoma (MCL)
  32. Follicular Lymphoma: Treatment Progress
  33. Marginal Zone Lymphoma (MZL): Treatment Updates
  34. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
  35. Transplantation as a Treatment Option for Blood Cancers
  36. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
  37. Treatment Update on Mantle Cell Lymphoma (MCL)Part I of Living with Mantle Cell Lymphoma
  38. Caregiving for Your Loved One with Mantle Cell Lymphoma
  39. For Caregivers: Coping with a Loved One’s Waldenstrom’s Macroglobulinemia (WM)
Back to Top

Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.